Courtesy www.news18.com
Pune: The Serum Institute of India (SII) is currently developing another vaccine with US drug-maker Novavax. Serum’s CEO Adar Poonawalla said on Saturday he hopes to launch the new vaccine ‘Covovax’ by June.
Covovax has been found to be 89.3 per cent effective in a UK trial.
“Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!” Poonawalla tweeted this afternoon.
Poonawalla’s firm is already making Covishield, developed in partnership with the Oxford University and British-Swedish firm AstraZeneca. Covishield and Bharat Biotech’s Covaxin are being used in the first phase of vaccination process in India.
Also Read: Serum Institute Of India Applies For Study Trial Of Novavax Vaccine
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
Hyderabad: Allu Arjun’s woes keep mounting. In a worrying development, protesters stormed Allu Arjun’s Jubilee…
This website uses cookies.